Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Polsky

Showing results (101-110 of 116) with videos related to

Pageof 12
Sort By:
Cancer Research|February 24, 2011
Integrative genomics identifies molecular alterations that challenge the linear model of melanoma progressionAmy E Rose, Laura Poliseno, Jinhua Wang, et al.
American Journal of Translational Research|December 8, 2009
Developing a multidisciplinary prospective melanoma biospecimen repository to advance translational researchLindsay G Wich, Heather K Hamilton, Richard L Shapiro, et al.
The Lancet. Oncology|February 15, 2021
Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation studyMahrukh M Syeda, Jennifer M Wiggins, Broderick C Corless, et al.
Cancer Management and Research|May 26, 2018
<i>MC1R</i> variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP projectElena Tagliabue, Sara Gandini, Rino Bellocco, et al.
Journal of the American Academy of Dermatology|January 25, 2016
Acral melanocytic lesions in the United States: Prevalence, awareness, and dermoscopic patterns in skin-of-color and non-Hispanic white patientsReshmi Madankumar, Priyanka V Gumaste, Kathryn Martires, et al.
The Lancet. Oncology|April 18, 2025
Clinical validation of droplet digital PCR assays in detecting BRAF<sup>V600</sup>-mutant circulating tumour DNA as a prognostic biomarker in patients with resected stage III melanoma receiving adjuvant therapy (COMBI-AD): a biomarker analysis from a double-blind, randomised phase 3 trialMahrukh M Syeda, Georgina V Long, James Garrett, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 9, 2026
Age-specific melanoma risk associated with nevi: a pooled analysis from the M-SKIP projectGiulia Doi, Aurora Gaeta, Simone Ribero, et al.
Journal of the American Academy of Dermatology|November 11, 2024
SpotCheck: A skin cancer diagnostic accuracy study comparing teledermoscopy with and without electrical impedance spectroscopy to in-person dermatologist evaluation of patient-identified lesions concerning them for skin cancerJenne P Ingrassia, Shirin Bajaj, Avani Kolla, et al.
Archives of Dermatology|April 23, 2008
The diagnostic performance of expert dermoscopists vs a computer-vision system on small-diameter melanomasRobert J Friedman, Dina Gutkowicz-Krusin, Michele J Farber, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 19, 2024
Association of MC1R variants with melanoma risk and interaction with sun exposure: An M-SKIP projectIrene Stefanaki, Oriana D'Ecclesiis, Silvano Vignati, et al.
Pageof 12

Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Cancer Research|February 24, 2011
Integrative genomics identifies molecular alterations that challenge the linear model of melanoma progressionAmy E Rose, Laura Poliseno, Jinhua Wang, et al.
American Journal of Translational Research|December 8, 2009
Developing a multidisciplinary prospective melanoma biospecimen repository to advance translational researchLindsay G Wich, Heather K Hamilton, Richard L Shapiro, et al.
The Lancet. Oncology|February 15, 2021
Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation studyMahrukh M Syeda, Jennifer M Wiggins, Broderick C Corless, et al.
Cancer Management and Research|May 26, 2018
<i>MC1R</i> variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP projectElena Tagliabue, Sara Gandini, Rino Bellocco, et al.
Journal of the American Academy of Dermatology|January 25, 2016
Acral melanocytic lesions in the United States: Prevalence, awareness, and dermoscopic patterns in skin-of-color and non-Hispanic white patientsReshmi Madankumar, Priyanka V Gumaste, Kathryn Martires, et al.
The Lancet. Oncology|April 18, 2025
Clinical validation of droplet digital PCR assays in detecting BRAF<sup>V600</sup>-mutant circulating tumour DNA as a prognostic biomarker in patients with resected stage III melanoma receiving adjuvant therapy (COMBI-AD): a biomarker analysis from a double-blind, randomised phase 3 trialMahrukh M Syeda, Georgina V Long, James Garrett, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 9, 2026
Age-specific melanoma risk associated with nevi: a pooled analysis from the M-SKIP projectGiulia Doi, Aurora Gaeta, Simone Ribero, et al.
Journal of the American Academy of Dermatology|November 11, 2024
SpotCheck: A skin cancer diagnostic accuracy study comparing teledermoscopy with and without electrical impedance spectroscopy to in-person dermatologist evaluation of patient-identified lesions concerning them for skin cancerJenne P Ingrassia, Shirin Bajaj, Avani Kolla, et al.
Archives of Dermatology|April 23, 2008
The diagnostic performance of expert dermoscopists vs a computer-vision system on small-diameter melanomasRobert J Friedman, Dina Gutkowicz-Krusin, Michele J Farber, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 19, 2024
Association of MC1R variants with melanoma risk and interaction with sun exposure: An M-SKIP projectIrene Stefanaki, Oriana D'Ecclesiis, Silvano Vignati, et al.
Pageof 12